Sativa Wellness works toward becoming one of the best-known wellness brands

Sativa Wellness Group Inc is a CBD wellness company.

The company manages the cultivation of raw materials, owns extraction, packaging and testing facilities, and is focused on developing consumer products under the Goodbody brand.

The product range includes CBD based gels, balms, capsules, tinctures, gummies, and other products. Geographically, it derives a majority of revenue from Europe.

(, , ) has reported its busiest day yet for PCR tests, with 850 booked on Monday and generating GBP100,000 of revenue.

Most of these were COVID-19 tests for travellers, but the proportion of blood tests being booked is growing consistently, added the Aquis-listed group.

Demand for PCR tests requested by the governments of the 220 countries outside the UK is expected to continue into next year, added Sativa, which will give the blood testing part of the business time fully to develop.

Geremy Thomas, executive chairman, said: “The 850 customers received excellent treatment at the hands of our amazing staff and pharmacy partners as demonstrated by our ratings and reviews.

(, , ) has launched an online telemedical service to coincide with the opening of its 70th Goodbody clinic.

The Virtual GP service gives all its customers the opportunity to follow up their wellness test results with a virtual medical consultation.

Sativa Wellness Group Inc (AQSE:SWEL, CSE:SWEL, OTC:SCNNF, FRA:484) said it launched a full membership scheme through its website and a new product range to include larger bottles of CBD oil.

For members, 20% CBD oil in 30ml bottles will be 20% cheaper and 20% stronger than the cheapest CBD on the market, the company said.

Sativa Wellness Group’s Geremy Thomas joins Proactive London to speak about the launch of their online telemedical service to coincide with the opening of its 70th Goodbody clinic.

The Virtual GP service gives all its customers the opportunity to follow up their wellness test results with a virtual medical consultation. This contract with the GP service is the next step in the company’s strategy to develop a portfolio of private healthcare services.